Search results
Results From The WOW.Com Content Network
Merck & Co. was confiscated following the First World War and set up as an independent company in the United States. [14] [15] Today, the US company, which operates as Merck Sharp and Dohme (MSD) outside the U.S. and Canada, has about 68,000 employees (December 2021) in 120 countries. It is one of the top 5 pharmaceutical companies worldwide ...
Four of these, Tysabri (Biogen Idec/Elan), Actemra (Hoffmann-La Roche/Chugai), Entyvio (Millenium Pharma/Takeda) and Keytruda (Merck/MSD), are licensed drugs. [ 4 ] [ failed verification ] In 2010, LifeArc signed a deal with the drug company AstraZeneca to share chemical compounds to help identify potential treatments for serious diseases.
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey, and is named for Merck Group, founded in Germany in 1668, of which it was once the American arm. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. It is one of the largest pharmaceutical ...
Coat of arms of the Darmstadt branch of the Merck family Coat of arms of the Hamburg branch of the Merck family Engel-Apotheke. The Merck family is a German noble family of industrialists and bankers, known for establishing the world's oldest pharmaceutical company Merck, its American former subsidiary Merck & Co. (MSD), which is now an independent company, as well as the Hamburg merchant bank ...
The Merck Manuals (outside the U.S. and Canada: The MSD Manuals; Chinese: 默沙东诊疗手册; pinyin: Mòshādōng Zhěnliáo Shǒucè) are medical references published by the American pharmaceutical company Merck & Co. (known as MSD outside the United States and Canada), that cover a wide range of medical topics, including disorders, tests, diagnoses, and drugs.
(Reuters) -Merck on Wednesday agreed to buy privately held biotech EyeBio for as much as $3 billion, as it looks to diversify its portfolio of experimental drugs with treatments for eye diseases.
Richard T. Clark is a former chairman of the Merck & Co. (MSD) pharmaceutical company, a position he held from 2007 to 2011. His previous leadership positions at Merck & Co. include CEO (2005–2010), [1] president (2005–2009) and president of the Merck & Co. manufacturing division (2003–2005).
Kenneth Carleton Frazier (born December 17, 1954) is an American business executive. He is executive chairman and former CEO of the pharmaceutical company Merck & Co. (known as MSD outside of North America).